Balchem (BCPC) Cost of Revenue (2010 - 2026)

Balchem (BCPC) has 17 years of Cost of Revenue data on file, last reported at $21.1 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $21.1 million, up 24.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $79.5 million (down 61.04% YoY), and the FY2025 annual result was $75.4 million, down 87.79% from the prior year.
• Cost of Revenue rose to $21.1 million in Q1 2026 per BCPC's latest filing, from $20.1 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $565.3 million in Q4 2023 and troughed at -$430.6 million in Q4 2022.
• A 5-year average of $66.1 million and a median of $19.3 million in 2025 frame the typical range for Cost of Revenue.
• On a YoY basis, Cost of Revenue climbed as much as 1036.04% in 2022 and fell as far as 2939.47% in 2022.
• A 5-year view of Cost of Revenue shows it stood at -$430.6 million in 2022, then jumped by 231.27% to $565.3 million in 2023, then plunged by 72.81% to $153.7 million in 2024, then tumbled by 86.95% to $20.1 million in 2025, then rose by 5.19% to $21.1 million in 2026.
• Business Quant data shows BCPC's Cost of Revenue at $21.1 million in Q1 2026, $20.1 million in Q4 2025, and $19.1 million in Q3 2025.